|
|
Efficacy of Yiqi Weixue Capsules in the Treatment of Iron Deficiency Anemia in Pregnancy and Its Effect on Iron Metabolism and Pregnancy Outcome |
SHENG Jie |
First-author's address: People's Hospital of Huantai County, Shandong Province, Huantai 256400, China |
|
|
Abstract Objective: To explore and analyze the efficacy of Yiqi Weixue Capsules in the treatment of patients with iron deficiency anemia during pregnancy and its effect on iron metabolism and pregnancy outcome. Method: A total of 90 patients with iron deficiency anemia during pregnancy were admitted to the Outpatient Department of People's Hospital of Huantai County from May 2021 to May 2022 were divided into two groups by random number table method, there were 45 cases in each group, and the control group was given Iron Dextran Oral Solution and Vitamin C combined treatment, the observation group was additionally treated with Yiqi Weixue Capsules on the basis of the control group, treatment for 12 weeks. The clinical efficacy, changes of blood routine indexes and iron metabolism indexes before and after treatment were compared between the two groups, and the pregnancy outcomes and adverse reactions of the patients were also observed. Result: Compared with the control group, the total clinical effective rate of the observation group was higher, and the difference was statistically significant (P<0.05). Compared with the control group after treatment, Hb, MCV, SI, TSAT, SF in the observation group were higher, and STFR in the observation group was lower, the differences were statistically significant (P<0.05). There were no significant differences in adverse pregnancy outcomes and adverse reactions between the two groups (P>0.05). Conclusion: Yiqi Weixue Capsules combined with Iron Dextran Oral Solution and Vitamin C in the treatment of iron deficiency anemia during pregnancy can obtain higher clinical total effective rate. The results showed higher advantages, and at the same time, there were no adverse reactions, and the safety was guaranteed.
|
Received: 12 December 2022
|
|
|
|
|
|
|